Treatment of Obsessive-Compulsive Disorders

被引：0
作者：
不详
机构：
来源：
The Indian Journal of Pediatrics | 1997年 / 64卷 / 4期
关键词：
Neonatal Intensive Care Unit; Fluvoxamine; Cisapride; Terfenadine; Astemizole;
D O I：
10.1007/BF02737763
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：535 / 535
相关论文
共 50 条
  • [11] Obsessive-Compulsive DisorderTreatment Options
    Lawrence T. Park
    James W. Jefferson
    John H. Greist
    CNS Drugs, 1997, 7 : 187 - 202
  • [12] Metacognitive Therapy (MCT), Fluvoxamine, and Combined Treatment in Improving Obsessive-Compulsive, Depressive and Anxiety Symptoms in Patients with Obsessive-Compulsive Disorder (OCD)
    Shareh, Hossein
    Gharraee, Banafsheh
    Atef-Vahid, Mohammad Kazem
    Eftekhar, Mehrdad
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2010, 4 (02) : 17 - 25
  • [13] Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder.
    Kochan L.D.
    Qureshi A.I.
    Fallon B.A.
    Current Psychiatry Reports, 2000, 2 (4) : 327 - 334
  • [14] Management of Schizophrenia with Obsessive-Compulsive Features
    Hwang, Michael Y.
    Kim, Sung-Wan
    Yum, Sun Young
    Opler, Lewis A.
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2009, 32 (04) : 835 - +
  • [15] Drug Therapy for Obsessive-Compulsive Disorder
    Khan, Seher A.
    US PHARMACIST, 2023, 48 (05) : 8 - 12
  • [16] Obsessive-compulsive symptoms in schizophrenia: a review
    Grover, Sandeep
    Sahoo, Swapnajeet
    Surendran, Indu
    ACTA NEUROPSYCHIATRICA, 2019, 31 (02): : 63 - 73
  • [17] Network Analysis for Predicting Treatment Response in Patients with Obsessive-Compulsive Disorder
    Davoudi, Mohammadreza
    Pourshahbaz, Abbas
    Dolatshahi, Behrooz
    Nazeriastaneh, Ali
    Poshtmashhadi, Marjan
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2023, 17 (04)
  • [18] Schizophrenia, obsessive-compulsive symptoms and treatment with aripiprazole and fluvoxamine: a case report
    Nolfe, G.
    Petrella, C.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2007, 13 (02): : 255 - 257
  • [19] Obsessive-compulsive disorder, 5-HTTLPR polymorphism and treatment response
    Di Bella D.
    Erzegovesi S.
    Cavallini M.C.
    Bellodi L.
    The Pharmacogenomics Journal, 2002, 2 (3) : 176 - 181
  • [20] Open-Label Study of Duloxetine for the Treatment of Obsessive-Compulsive Disorder
    Dougherty, Darin D.
    Corse, Andrew K.
    Chou, Tina
    Duffy, Amanda
    Arulpragasam, Amanda R.
    Deckersbach, Thilo
    Jenike, Michael A.
    Keuthen, Nancy J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (02) : 1 - 4
12345